Skip to main content

Search

Study Title Study Sponsor Status Study Drug Trial Phase Study Protocol Number Site
A Multicentre, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults and Adolescents with Severe Uncontrolled Asthma (NAVIGATOR) AstraZeneca Ongoing Tezepelumab 3 D5180C00007 King Abdulaziz University Hospital (Jeddah), King Khalid University Hospital (Riyadh), King Abdulaziz Medical City NG (Jeddah)
A two part seamless, open label, multi-center study to investigate the safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of RO7034067 in infants with type 1 spinal muscular atrophy. Roche Terminated Risdiplam 2 BP39056 King Faisal Specialist Hospital and Research Center (Riyadh)
The effect of cinnamon supplementation on ovulation induction in women with polycystic ovary syndrome, Jeddah 2018: Randomized Double-Blind Placebo-controlled trial King Abdulaziz University (Jeddah) Ongoing Cinnamon 3 100-18 King Abdulaziz University Hospital (Jeddah)
Apixaban in Patients with Left Ventricular Thrombus, CLEAN-LV Study Saud Al Babtain Cardiac Center Ongoing Apixaban 4 2018-08 Saud Al-Babtain Cardiac Center (Dammam)N/A
"AURIGA / An observationAl stUdy pRogram toInvestiGate the effectiveness of intravitreal Aflibercept indiabetic macular edema and/or macular edema secondary toretinal vein occlusion in a real world setting." Bayer Ongoing Aflibercept 4 191 57 King Faisal Specialist Hospital and Research Center (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah), King Khalid University Hospital (Riyadh)
An observational, prospective cohort study to evaluate the safety and effectiveness of Remsima® in the treatment of inflammatory bowel disease among Saudi Arabia patients diagnosed with Crohn’s disease, ulcerative colitis, or fistulizing CD Hikma Pharmaceuticals Ongoing Remsima 4 RMS-KSA-20 King Abdulaziz University Hospital (Jeddah)
Randomized, two-way, two-period, single injectable dose, open-label, crossover, bioequivalence study to compare Enoxa pre-filled syringes (80 mg enoxaparin sodium) versus Clexane® pre-filled syringes (80 mg enoxaparin sodium), in healthy subjects under fasting condition. MEDIS Laboratories Ongoing Enoxa / Enoxaparin BE 21-2017 v.02 Saudi Ajal
Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma SWOG (Southwest Oncology Group) Ongoing Ibrutinib 3 A051301 King Faisal Specialist Hospital and Research Center (Riyadh)
OPEN LABEL, RANDOMIZED, SINGLE SITE CLINICAL TRIAL TO COMPARE THE SAFETY & EFFICACY OF HERBAL MELANIN EXTRACTED FROM NIGELLA SATIVA SEEDS VS STANDARD OF CARE TREATMENT IN TREATING GASTRITIS PATIENTS KAIMRC Rejected Melanole NIGELLA SATIVA 2 RC15/152/R N/A
ATOS study_A 12–month prospective observational study assessing the real-world clinical effectiveness, safety and health-economic benefits of Toujeo® initiation after oral antidiabetic drug failure in insulin-naïve patients with type 2 diabetes mellitus SANOFI Ongoing TOUJEO 4 OBS14708 King Abdulaziz University Hospital (Jeddah), Dr. Ghassan N. Pharaon General Hospital (Jeddah), Dallah Hospital (Riyadh), Alzafer Hospital (Najran), Dr. Bakhsh Hospital (Jeddah), Saudi German Hospital (Jeddah), Arrawdha General Hospital (Dammam), Almana Hospital (Jubail), Almouwasat Hospital (Dammam), Specialized Medical Center (Riyadh)
View 491 - 500 From 723